Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

RE-VANA THERAPEUTICS LTD

Company number NI638333

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
30 May 2024 AA Unaudited abridged accounts made up to 31 May 2023
19 Mar 2024 CS01 Confirmation statement made on 14 March 2024 with updates
01 Dec 2023 SH01 Statement of capital following an allotment of shares on 29 November 2023
  • GBP 209.6941
27 Jun 2023 CS01 Confirmation statement made on 27 June 2023 with updates
22 Feb 2023 AA Micro company accounts made up to 31 May 2022
07 Dec 2022 MA Memorandum and Articles of Association
06 Dec 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
30 Nov 2022 SH01 Statement of capital following an allotment of shares on 28 November 2022
  • GBP 161.3107
29 Nov 2022 AP01 Appointment of Dr Robert Logan Avery as a director on 28 November 2022
29 Nov 2022 TM01 Termination of appointment of Raghu Raj Singh Thakur as a director on 28 November 2022
29 Nov 2022 TM01 Termination of appointment of Brian Mccaul as a director on 28 November 2022
29 Nov 2022 TM01 Termination of appointment of Kieran Francis Rooney as a director on 28 November 2022
12 Aug 2022 CS01 Confirmation statement made on 6 August 2022 with updates
23 Feb 2022 AA Micro company accounts made up to 31 May 2021
19 Jan 2022 SH03 Purchase of own shares.
12 Jan 2022 SH06 Cancellation of shares. Statement of capital on 10 January 2022
  • GBP 104.3718
01 Dec 2021 SH03 Purchase of own shares.
24 Nov 2021 SH01 Statement of capital following an allotment of shares on 17 November 2021
  • GBP 105.4496
24 Nov 2021 SH06 Cancellation of shares. Statement of capital on 17 November 2021
  • GBP 105.1496
23 Nov 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES10 ‐ Resolution of allotment of securities
18 Nov 2021 AP01 Appointment of Ms Anna Sumeray as a director on 17 November 2021
18 Nov 2021 TM01 Termination of appointment of James Anthony Sharkey as a director on 17 November 2021
23 Aug 2021 CS01 Confirmation statement made on 6 August 2021 with updates
07 Apr 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
30 Mar 2021 SH01 Statement of capital following an allotment of shares on 26 March 2021
  • GBP 105.7783